(MENAFN- AzerNews) Amazon.com Inc is offering a $5 monthly subscription plan for
U.S. Prime members that will cover a range of generic drugs and
their doorstep delivery, furthering the ecommerce giant's push into
healthcare,reuters says.
The program, named RxPass, includes more than 50 medications
addressing over 80 chronic conditions such as high blood pressure,
anxiety, diabetes and male pattern baldness, Vin Gupta, Amazon
Pharmacy's chief medical officer, told Reuters.
However, customers enrolled in Medicare, Medicaid or any other
government healthcare program will not be able to enroll in Amazon
Pharmacy's RxPass service.
The average Prime member would save about $100 per year with
RxPass, John Love, vice president of Amazon Pharmacy, said in an
interview. Amazon Prime members in most U.S. states can sign up for
the program from Tuesday.
The flat $5 charge would be without insurance and on top of the
Prime membership fee, which costs $139 per year in the United
States.
The new service aligns with Amazon's ongoing focus on its
healthcare portfolio, which over the recent years has included
telehealth, drug delivery, fitness trackers, and cancer research.
read more
Amazon's purchase of online pharmacy PillPack in 2018 helped the
retail giant set up a prescription delivery and price-comparison
site. Now, its Pharmacy initiative poses a growing threat to
drugstore retailers CVS Health Corp and Walgreens Boots Alliance
Inc.
'We believe a lot of Americans, particularly those that suffer
from a chronic illness, are going to benefit from just Amazon's
participation in pharmacy, the ability to get high-quality
experience delivered to your door at low cost,' Love said.
---
MENAFN24012023000195011045ID1105472124
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.